These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9868341

  • 1. [Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2].
    Steegmann JL, Granados E, Vázquez L, de la Cámara R, Peñarrubia MJ, Fernández-Contreras E, Quiroga JA, Fernández Rañada JM.
    Sangre (Barc); 1998 Oct; 43(5):443-6. PubMed ID: 9868341
    [Abstract] [Full Text] [Related]

  • 2. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
    Steegmann JL, Granados E, Peñarrubia MJ.
    Haematologica; 1997 Oct; 82(6):731-2. PubMed ID: 9580090
    [No Abstract] [Full Text] [Related]

  • 3. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia.
    Mahon FX, Fabères C, Montastruc M, Si-Mour S, Boiron JM, Marit G, Bilhou-Nabera C, Cony-Makhoul P, Pigneux A, Bernard P, Broustet A, Reiffers J.
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S33-7. PubMed ID: 8769698
    [Abstract] [Full Text] [Related]

  • 4. [Interferon alpha--the drug of choice for patients with chronic myeloid leukemia].
    Klamová H, Vítek A, Michalová K, Brezinová J, Moravcová J, Jelínek J, Cermák J.
    Cas Lek Cesk; 1998 Sep 21; 137(18):552-6. PubMed ID: 9818464
    [Abstract] [Full Text] [Related]

  • 5. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug 21; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 6. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
    Li YF, Deng ZK, Xuan HB, Zhu JB, Ding BH, Liu XN, Chen BA.
    Chin Med J (Engl); 2009 Jun 20; 122(12):1413-7. PubMed ID: 19567163
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-alpha.
    Branford S, Hughes T, Milner A, Koelmeyer R, Schwarer A, Arthur C, Filshie R, Moreton S, Lynch K, Taylor K.
    Cancer; 2007 Aug 15; 110(4):801-8. PubMed ID: 17607681
    [Abstract] [Full Text] [Related]

  • 8. Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
    Cervantes F, Sureda A, Hernández-Boluda JC, Martino R, Brunet S, Borrego D, Antich JL, Montserrat E.
    Haematologica; 2001 Dec 15; 86(12):1281-6. PubMed ID: 11726320
    [Abstract] [Full Text] [Related]

  • 9. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia].
    Iványi JL, Marton E, Kereskai L, Kiss Z, Pajor L.
    Orv Hetil; 2000 Nov 19; 141(47):2527-33. PubMed ID: 11143285
    [Abstract] [Full Text] [Related]

  • 10. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM, Talpaz M, O'Brien S, Smith TL, Giles FJ, Faderl S, Thomas DA, Garcia-Manero G, Issa JP, Andreeff M, Kornblau SM, Koller C, Beran M, Keating M, Rios MB, Shan J, Resta D, Capdeville R, Hayes K, Albitar M, Freireich EJ, Cortes JE.
    Clin Cancer Res; 2002 Jul 19; 8(7):2177-87. PubMed ID: 12114418
    [Abstract] [Full Text] [Related]

  • 11. Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia.
    Sacchi S, Cortes J, Kantarjian H, Talpaz M.
    Hematopathol Mol Hematol; 2002 Jul 19; 11(1):41-7. PubMed ID: 9439979
    [Abstract] [Full Text] [Related]

  • 12. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E, Stecová N, Kafková A, Fricová M, Svorcová E.
    Vnitr Lek; 2002 May 19; 48(5):380-3. PubMed ID: 12061203
    [Abstract] [Full Text] [Related]

  • 13. Imatinib mesylate in Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon alpha.
    Tóthová E, Kafková A, Fricová M, Benová B, Kirschnerová G, Tóthová A.
    Neoplasma; 2005 May 19; 52(1):63-7. PubMed ID: 15739029
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A, Molnár L, Nagy A, Dávid M, Alizadeh H, Kecskés M, Vidra T, Kereskai L, Pajor L, Losonczy H.
    Orv Hetil; 2000 Nov 26; 141(48):2601-4. PubMed ID: 11141958
    [Abstract] [Full Text] [Related]

  • 15. [Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha].
    Molnár L, Nagy A, Dávid M, Szomor A, Méhes G, Kovács G, Losonczy H.
    Orv Hetil; 2004 Apr 25; 145(17):901-7. PubMed ID: 15170967
    [Abstract] [Full Text] [Related]

  • 16. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses.
    Peñarrubia MJ, Odriozola J, González C, Massagué I, Miguel A, González San Miguel JD, Pérez Encinas M, Lavilla E, Giraldo MP, Casado LF, Ferrer S, Steegmann JL, Spanish Group on IFN and CML.
    Ann Hematol; 2003 Dec 25; 82(12):750-8. PubMed ID: 14517691
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
    Anstrom KJ, Reed SD, Allen AS, Glendenning GA, Schulman KA.
    Cancer; 2004 Dec 01; 101(11):2584-92. PubMed ID: 15493041
    [Abstract] [Full Text] [Related]

  • 18. [Interferon alpha in the treatment of chronic myeloid leukemia].
    Tóthová E, Fricová M, Stecová N, Svorcová E, Surová M, Kafková A, Guman T, Mudronová B.
    Vnitr Lek; 1996 May 01; 42(5):327-30. PubMed ID: 8768291
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience of antibodies to interferon-alpha during treatment of chronic myeloid leukemia.
    Russo D, Candoni A, Grattoni R.
    J Interferon Cytokine Res; 1997 Jul 01; 17 Suppl 1():S47-9. PubMed ID: 9241616
    [Abstract] [Full Text] [Related]

  • 20. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation.
    Steegmann JL, Casado LF, Tomás JF, Sanz-Rodríguez C, Granados E, de la Cámara R, Alegre A, Vázquez L, Ferro MT, Figuera A, Arranz R, Fernández-Rañada JM.
    Bone Marrow Transplant; 1999 Mar 01; 23(5):483-8. PubMed ID: 10100563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.